CVE-2026-1031
mediumIBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting.
IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
CVSS
6.1
6.1 (CVSS v3.1)
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N Severity source: NVD CVSS v3.1 (psirt@us.ibm.com)
Timeline (UTC)
Published: 2026-09-18 16:17
Modified: 2026-09-19 15:16
NVD status: Awaiting Analysis
Last synced 2 days ago
Verified against the source API 2026-10-27 06:54 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).
Affected products
Not reported by the source (unknown — not "none").
Weakness classification (CWE)
Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.
Mitigation & advisories
No vendor advisory or patch reference tagged by NVD. Check the references below.
References
- https://www.ibm.com/support/pages/node/7286490 psirt@us.ibm.com
Data sources
NVD CVE API 2.0 — fetched 2026-10-27 06:54 UTC · record ↗